A

Arialys Therapeutics, Inc.

6 employees

Arialys Therapeutics is a pre-clinical stage company that develops auto-antibody focusing on neuroscience.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Health Care
Therapeutics
Medical

Date founded

2022

Funding rounds raised

Total raised

$58M

from 3 investors over 3 rounds

A

Arialys Therapeutics, Inc. raised $58M on September 12, 2023

Investors: Avalon BioVentures, MPM Capital and Catalys Pacific

FAQ